Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NOVELSTEM INTERNATIONAL CORP.

(NSTM)
 SummaryQuotesChartsNewsCompany 
Quotes 5-day view   Delayed Quote. Delayed Otc Markets
11/11/2021 11/12/2021 11/19/2021 11/22/2021 12/03/2021 Date
0.31(c) 0.31(c) 0.31(c) 0.31(c) 0.31(c) Last
5 100 20 400 23 500 2 100 18 097 Volume
0.00% 0.00% 0.00% 0.00% 0.00% Change
More quotes
Company
NovelStem International Corp. is primarily focused on the development and commercialization of diagnostic technology. The Company predicts patientsÔÇÖ anti-cancer drug resistance, which allows targeted cancer treatments and the potential to reduce resistance to chemotherapy. 
More about the company
All news about NOVELSTEM INTERNATIONAL CORP.
2020NovelStem Increases NewStem Ownership to 33% as NewStem Prepares for First-Half 2021 FD..
GL
2020NovelStem International Corp and Newstem Ltd. Announce New Research Collaborations for ..
CI
2019NovelStem International Corp.'s Equity Buyback announced on January 16, 2018, has expir..
CI
2018Hollywood Media Corp. will Change its Ticker to NSTM from HOLL
CI
2018Hollywood Media Corp. has Changed its Name to NovelStem International Corp
CI
2018Hollywood Media Corp. Announces Board Changes
CI
2018NewStem Ltd. announced that it expects to receive $4 million in funding from Hollywood ..
CI
2018Hollywood Media Corp. Provides Update on Mechanics of Special One-Time Distribution, Pa..
CI
2018Hollywood Media Corp. Announces Cash Distribution, Payable March 30, 2018
CI
2018Hollywood Media Corp. authorizes a Buyback Plan.
CI
2018Hollywood Media Corp. announces an Equity Buyback for 1,000,000 shares.
CI
More news
News in other languages on NOVELSTEM INTERNATIONAL CORP.

- No features available -

More news
Chart NOVELSTEM INTERNATIONAL CORP.
Duration : Period :
NovelStem International Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Ayelet Dilion-Mashiah Chief Executive Officer
Jan Herman Loeb Chairman
Mitchell Rubenstein Director
Eric I. Richman Director
Jerry Wolasky Director
Sector and Competitors
1st jan.Capi. (M$)
NOVELSTEM INTERNATIONAL CORP.55.00%15
GILEAD SCIENCES, INC.19.40%87 255
BIONTECH SE310.30%83 098
REGENERON PHARMACEUTICALS31.47%66 409
WUXI APPTEC CO., LTD.26.31%65 758
VERTEX PHARMACEUTICALS-13.76%51 819